{
  "DOI": "10.1038/s41431-020-0607-y",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-020-0607-y",
  "alternative-id": [
    "607"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "12 December 2019"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "18 February 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "3 March 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "25 March 2020"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Mourby",
      "given": "Miranda",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Morrison",
      "given": "Michael",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        3,
        25
      ]
    ],
    "date-time": "2020-03-25T21:03:00Z",
    "timestamp": 1585170180000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        20
      ]
    ],
    "date-time": "2023-05-20T21:01:39Z",
    "timestamp": 1684616499000
  },
  "funder": [
    {
      "DOI": "10.13039/501100000275",
      "award": [
        "RPG-2017-330"
      ],
      "doi-asserted-by": "publisher",
      "name": "Leverhulme Trust"
    },
    {
      "DOI": "10.13039/501100000269",
      "award": [
        "ES/P002943/1"
      ],
      "doi-asserted-by": "publisher",
      "name": "RCUK | Economic and Social Research Council"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        8
      ]
    ],
    "date-time": "2024-02-08T13:43:37Z",
    "timestamp": 1707399817415
  },
  "is-referenced-by-count": 10,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "7",
  "issued": {
    "date-parts": [
      [
        2020,
        3,
        25
      ]
    ]
  },
  "journal-issue": {
    "issue": "7",
    "published-print": {
      "date-parts": [
        [
          2020,
          7
        ]
      ]
    }
  },
  "language": "en",
  "link": [
    {
      "URL": "http://www.nature.com/articles/s41431-020-0607-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "979-981",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2020,
        3,
        25
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        3,
        25
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2020,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "607_CR1",
      "unstructured": "Council Regulation (EU) 536/2014 of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC [2014] OJ L 158/1, Article 90. This reflects the prohibition in Article 13 Oviedo Convention, to which some EU Member States are party."
    },
    {
      "key": "607_CR2",
      "unstructured": "Council Regulation (EC) 1394/2007 of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 [2007] OJ L324/121."
    },
    {
      "DOI": "10.1038/s41431-018-0309-x",
      "author": "MC Cornel",
      "doi-asserted-by": "publisher",
      "first-page": "484",
      "journal-title": "Eur J Hum Genet",
      "key": "607_CR3",
      "unstructured": "Cornel MC, Howard HC, Lim D, Bonham VL, Wartiovaara K. Moving towards a cure in genetics: what is needed to bring somatic gene therapy to the clinic? Eur J Hum Genet. 2019;27:484–7. https://doi.org/10.1038/s41431-018-0309-x. Accessed 21 Feb 2020.",
      "volume": "27",
      "year": "2019"
    },
    {
      "DOI": "10.1038/d41586-018-07641-1",
      "author": "C Bender",
      "doi-asserted-by": "publisher",
      "first-page": "S20",
      "journal-title": "Nature",
      "key": "607_CR4",
      "unstructured": "Bender C. Regulating the gene-therapy revolution. Nature. 2018;564:S20–S22. https://doi.org/10.1038/d41586-018-07641-1. Accessed 21 Feb 2020",
      "volume": "564",
      "year": "2018"
    },
    {
      "key": "607_CR5",
      "unstructured": "European Medicines Agency, ʻScientific recommendation on classification of advanced therapy medicinal products EMA/814824/2018ʼ, 21 November 2018. https://www.ema.europa.eu/en/documents/report/scientific-recommendation-classification-advanced-therapy-medicinal-products-codonoptimized-mrna_en.pdf. Accessed 17 March 2020."
    },
    {
      "key": "607_CR6",
      "unstructured": "Council Directive 2001/83/EC of 6 November 2001 on the Community code relating to medicinal products for human use [2001] OJ L311/67, Annex I, Part I, paragraph 3.2.1.1 (b)."
    },
    {
      "key": "607_CR7",
      "unstructured": "Ibid, Annex I, Part IV, paragraph 2.1."
    },
    {
      "key": "607_CR8",
      "unstructured": "Hempsted A. ‘CRISPR 101: Ribonucleoprotein (RNP) delivery’, addgene blog 6 September 2018 https://blog.addgene.org/crispr-101-ribonucleoprotein-rnp-delivery. Accessed 21 Feb 2020."
    },
    {
      "key": "607_CR9",
      "unstructured": "Council Directive 2001/18/EC of 12 March 2001 on the deliberate release into the environment of genetically modified organisms and repealing. Council Directive 90/220/EEC [2001] OJ L 106/1, Annex 1A, Part 1, para (1)."
    },
    {
      "key": "607_CR10",
      "unstructured": "European Commission, ‘The Rules Governing Medicinal Products in the European Union Vol 4: Guidelines on good manufacturing practice specific to advanced therapy medicinal products’ 22 November 2017, p. 80. https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-4/2017_11_22_guidelines_gmp_for_atmps.pdf. Accessed 25 Feb 2020."
    },
    {
      "key": "607_CR11",
      "unstructured": "Department of Health and Human Services, National Institutes of Health. NIH guidelines for research involving recombinant or synthetic nucleic acid molecules, 2016. https://osp.od.nih.gov/wp-content/uploads/2016/05/NIH_Guidelines.pdf. Accessed 21 Feb 2020."
    },
    {
      "DOI": "10.1016/B978-0-12-802211-5.00010-2",
      "doi-asserted-by": "crossref",
      "key": "607_CR12",
      "unstructured": "Stephenson FH. ‘Recombinant DNA’ in calculations for molecular biology and biotechnology. Elsevier (2016). https://www.sciencedirect.com/book/9780128022115/calculations-for-molecular-biology-and-biotechnology#book-info. Accessed 17 March 2020."
    },
    {
      "key": "607_CR13",
      "unstructured": "Case C‑528/16 Confédération paysanne \u0026 ors v Premier ministre, Ministre de l’Agriculture, de l’Agroalimentaire et de la Forêt (25 July 2018), http://curia.europa.eu/juris/document/document.jsf;jsessionid=9ea7d0f130da2186623a9dfe47d78dfe9e06ce39e17e.e34KaxiLc3eQc40LaxqMbN4Pb3qTe0?text=\u0026docid=204387\u0026pageIndex=0\u0026doclang=EN\u0026mode=req\u0026dir=\u0026occ=first\u0026part=1\u0026cid=486410. Accessed 17 March 2020."
    },
    {
      "DOI": "10.1111/reel.12291",
      "author": "K Garnett",
      "doi-asserted-by": "publisher",
      "first-page": "349",
      "journal-title": "RECEIL",
      "key": "607_CR14",
      "unstructured": "Garnett K. Hold your pipettes: The European Court of Justice’s findings in Confédération Paysanne \u0026 Others stirs GMOtions. RECEIL. 2019;28:349–55. https://doi.org/10.1111/reel.12291. Accessed 21 Feb 2020.",
      "volume": "28",
      "year": "2019"
    },
    {
      "key": "607_CR15",
      "unstructured": "Council Regulation (EC) 1394/2007 of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/83/EC and Regulation (EC) No 726/2004 [2007] OJ L324/121, Recital 9."
    },
    {
      "key": "607_CR16",
      "unstructured": "European Commission \u0026 European Medicines Agency, ‘European Commission—DG Health and Food Safety and European Medicines Agency Action Plan on ATMPs’, 2018. https://www.ema.europa.eu/en/documents/other/european-commission-dg-health-food-safety-european-medicines-agency-action-plan-advanced-therapy_en.pdf. Accessed 21 Feb 2020."
    },
    {
      "DOI": "10.1146/annurev-med-112717-094629",
      "author": "B Coller",
      "doi-asserted-by": "publisher",
      "first-page": "289",
      "journal-title": "Annu Rev Med",
      "key": "607_CR17",
      "unstructured": "Coller B. Ethics of human genome editing. Annu Rev Med. 2019;70:289–305. https://doi.org/10.1146/annurev-med-112717-094629. Accessed 21 Feb 2020.",
      "volume": "70",
      "year": "2019"
    }
  ],
  "reference-count": 17,
  "references-count": 17,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-020-0607-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Gene therapy regulation: could in-body editing fall through the net?"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "28"
}